Sarah M. Kling MD, MPH , Simran Kripalani MD , Valeda Yong MD, MSEd , Juan Lucas Poggio MD
{"title":"The impact of federally legislated colon and rectal cancer screening programs and policy in the United States","authors":"Sarah M. Kling MD, MPH , Simran Kripalani MD , Valeda Yong MD, MSEd , Juan Lucas Poggio MD","doi":"10.1016/j.scrs.2024.101040","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Colorectal cancer (CRC) is the third leading cause of cancer deaths for men and women separately and the second leading cause of cancer deaths for men and women combined. CRC screening allows for cancer prevention, early treatment, or cure. Thus, screening can decrease the incidence and mortality of CRC. This supports the importance of making efforts to improve screening rates through public health programs and policy.</p></div><div><h3>Programs and Policy</h3><p>Government sponsored public health programs have been shown to be effective at increasing CRC screening rates at comparable costs across multiple regions and populations in the United States. Additionally, policy has been evolving to provide more comprehensive coverage of CRC screening tests.</p></div><div><h3>Conclusion</h3><p>Both public health programming and policy are important tools to increase CRC screening rates, with the ultimate goals of decreasing CRC incidence and mortality. CRC screening and its dissemination has been shown to be adoptable and cost effective, and should continue to be the focus of public health programming and policy efforts.</p></div>","PeriodicalId":55956,"journal":{"name":"Seminars in Colon and Rectal Surgery","volume":"35 3","pages":"Article 101040"},"PeriodicalIF":0.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Colon and Rectal Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043148924000393","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Colorectal cancer (CRC) is the third leading cause of cancer deaths for men and women separately and the second leading cause of cancer deaths for men and women combined. CRC screening allows for cancer prevention, early treatment, or cure. Thus, screening can decrease the incidence and mortality of CRC. This supports the importance of making efforts to improve screening rates through public health programs and policy.
Programs and Policy
Government sponsored public health programs have been shown to be effective at increasing CRC screening rates at comparable costs across multiple regions and populations in the United States. Additionally, policy has been evolving to provide more comprehensive coverage of CRC screening tests.
Conclusion
Both public health programming and policy are important tools to increase CRC screening rates, with the ultimate goals of decreasing CRC incidence and mortality. CRC screening and its dissemination has been shown to be adoptable and cost effective, and should continue to be the focus of public health programming and policy efforts.
期刊介绍:
Seminars in Colon and Rectal Surgery offers a comprehensive and coordinated review of a single, timely topic related to the diagnosis and treatment of proctologic diseases. Each issue is an organized compendium of practical information that serves as a lasting reference for colorectal surgeons, general surgeons, surgeons in training and their colleagues in medicine with an interest in colorectal disorders.